Durvalumab (Imfinzi) with etoposide and either carboplatin or cisplatin is available on the NHS. It is a possible treatment for extensive-stage small-cell lung cancer that has not been treated before ...
Around 2,400 people in England have ES-SCLC, of whom around 1,200 people will be eligible to receive Tecentriq plus carboplatin and etoposide. NICE noted that clinical trial evidence suggests ...
Most patients with metastatic germ cell tumors (GCTs) are considered to have a good prognosis: cure rates >90% have been reported since the introduction of bleomycin, etoposide and cisplatin (BEP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback